Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (5): 833-837    DOI: 10.31083/j.ejgo.2020.05.5214
Case Report Previous articles | Next articles
Individual management of cervical cancer during pregnancy
Yan qin Zhang1, Di Wu1, Meng qi Deng1, Xiang yu Chang1, Jin wei Miao1, *(), Yu mei Wu1
1Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, 100006, P. R. China
Download:  PDF(782KB)  ( 72 ) Full text   ( 7 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
The exact definition of cervical cancer during pregnancy has not yet been unified. Cervical cancer during pregnancy refering to cervical cancer found during pregnancy is widely accepted. With the phenomenon of late marriage and late childbearing globally, the incidence of cervical cancer during pregnancy is also increasing. Even though early screening for cervical cancer has had an enormous impact on incidence and mortality from cervical cancer worldwide, cervical cancer during pregnancy is still a major clinical problem due to the negligence and misunderstanding of early symptoms. At present, there is no global guideline for the treatment of cervical cancer during pregnancy. The clinicians can only treat according to there own experience and the patient's wishes. Here, we provide five cases of cervical cancer during pregnancy in our hospital.
Key words:  Cervical cancer during pregnancy      Treatment      Chemotherapy      Case     
Submitted:  31 March 2019      Accepted:  05 June 2019      Published:  15 October 2020     
Fund: 
ZYLX201705/Beijing Municipal Administration of Hospitals Clinical Medicine Development
*Corresponding Author(s):  JIN WEI MIAO     E-mail:  miaojinweigyn@163.com

Cite this article: 

Yan qin Zhang, Di Wu, Meng qi Deng, Xiang yu Chang, Jin wei Miao, Yu mei Wu. Individual management of cervical cancer during pregnancy. European Journal of Gynaecological Oncology, 2020, 41(5): 833-837.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.05.5214     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I5/833

[1] Yu Hui Lim, Sheow Lei Lim, Linda Xiao Hui Lin, Lay Tin Soh, Hoon Seng Khoo Tan, Richard Ming Chert Yeo, Timothy Yong Kuei Lim. Sequential Chemoradiation versus Radiation for the Adjuvant Treatment of Stage III Endometrioid Adenocarcinoma of the Uterus[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 705-712.
[2] Yanan Li, Dongge Wang, Xiaodong Li, Wangchao Zhang, Xianghua Huang, Yibin Liu. Appendix invasion of squamous cell carcinoma arising from ovarian mature cystic teratoma and resistant to combination chemotherapy with docetaxel and oxaliplatin: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 841-844.
[3] Joseph J. Noh, Sir-Yeon Hong, Byeong-gie Kim. Malignant perivascular epithelioid cell tumor (PEComa) of uterus: A case report with literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 495-499.
[4] Krittiya Somaketarin, Charuwan Tantipalakorn, Kittipat Charoenkwan, Prapaporn Suprasert, Jatupol Srisomboon. Survival outcomes of sex cord-stromal tumors of the ovary[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 563-568.
[5] Sigit Purbadi, Gregorius Tanamas, Lisa Novianti. Advanced stage ovarian cancer survival in Jakarta[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 587-590.
[6] J. An, G. Ruan, X.Y. Xie, Y.Q. Shi, X.D. Mao, B.H. Dong, P.M. Sun. Endometrial stromal nodule: report of 8 cases and literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 332-338.
[7] T. Shoji, E. Takatori, M. Kagabu, M. Futagami, Y. Yokoyama, H. Tokunaga, N. Yaegashi, T. Ohta, T. Watanabe, T Sugiyama. Relationship between usefulness of irinotecan and pegylated liposomal doxorubicin therapy and the UGT1A1 genotype in patients with recurrent ovarian cancer (TGCU 104 study)[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 380-385.
[8] H. Ishibashi, M. Miyamoto, T. Aoyama, H. Soyama, H. Matsuura, H. Iwahashi, M. Takano, K. Furuya. The effect of six scheduled cycles of neoadjuvant chemotherapy on prognosis in advanced ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 386-390.
[9] X.F. Xu, Q. Li, A.Y. Dai, H.J. Zhou, J.X. Ling. Neoadjuvant chemotherapy followed by radical surgery for Stage IB2 cervical cancer in pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 489-491.
[10] Chenchen Zhu, Hanyuan Liu, Zhen Shen, Yanhu Xie, Tianjiao Zhang, Björn Nashan, Dabao Wu, Ying Zhou. Treatment and survival outcomes from epithelial ovarian cancer in women aged 65 years or older[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 415-421.
[11] J. Yang, Y.J. Song, Y.J. Na, H.G. Kim. A Case of Fertility Sparing Surgery of Low-Grade Endometrial Stromal Sarcoma in Young Female[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 317-319.
[12] Y.H. Wang, J.M. Gong, Q. Tian, G. Shi, J.Y. Ruan. The endoscopic therapy of infant vaginal embryonal rhabdomyosarcoma: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 151-152.
[13] H.Ç. Özcan, Ö. Balat, M.G. Uğur, S. Sucu, N.B. Tepe, Ö.K. Karusercï, Z. Bozdağ. Extraperitoneal pelvic lymph node dissection with laparotomy in occult invasive cervical cancer found after a simple hysterectomy[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 982-987.
[14] L. N. Abaid, N. Zekry, A. Ronaghi, R. C. Kankus, B. H. Goldstein. Primary management of an extremely large, invasive mucinous ovarian adenocarcinoma: a case report[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1044-1046.
[15] A. Antar, H. AlJawad, A. AlMuslim, N. El-Majzoub. Isolated late recurrence of epithelial ovarian cancer in cervical lymph nodes[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1067-1069.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] B. Soltész, J. Lukács, A. Penyige, R. Póka, B. Nagy. Determination of miR-193b rs30236 single nucleotide polymorphism in ovarian cancer patients[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 547 -550 .
[3] Y. Li, C. Li, N. Li, L. Jiang, W. Yang, Y. Wang, B. Wu, C. Shi, Z. Zhu. RNAi silenced NUP88 gene suppresses growth and invasiveness of human breast cancer cell line MCF-7[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 634 -639 .
[4] M. Pakiž, L. Lukman, N. Kozar. Patients' and physicians' expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 781 -786 .
[5] T. Tomimatsu, S. Mabuchi, T. Tsuboyama, Y. Hori, S. Sekine, T. Kimura. Malignant transformation of uterine leiomyoma: suggested by clinical, imaging, histological, and genetic findings[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 879 -882 .
[6] Z. Protrka, P. Arsenijevic, N. Jovic, S. Zivanovic, J. Djuric, A. Dimitrijevic. A case of uterine torsion in term pregnancy associated with placental abruption and intrauterine fetal demise[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 287 -289 .
[7] T. Ueno, H. Yabushita, K. Iwasaki, A. Wakatsuki. Role of adiponectin and leptin in non-diabetic, non-obese patients with endometrial cancer[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 199 -204 .
[8] P. Pimsi, W. Santimaleeworagun, S. Therasakvichya, N. Saengsukkasemsak, A. Laocharoenkeat. The incidence and risk factors of severe neutropenia and febrile neutropenia due to chemotherapy among gynecologic cancer patients in Thailand[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 242 -246 .
[9] F. Lai-Tiong. Dermatomyositis revealing a 18-year breast cancer recurrence[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 292 -293 .
[10] M.F. Benoit, K.A. O'Hanlan, M.S. Sten, C.L. Kosnik, D.M. Struck, M.S. O'Holleran, J. Cuff, D.M. Halliday, E.A. Kent. Incidental appendectomy at the time of gynecologic surgery[J]. European Journal of Gynaecological Oncology, 2018, 39(3): 386 -389 .